Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Denosumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT06588153
What this trial is testing

The Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China

Who this might be right for
Glucocorticoid-induced Osteoporosis
Amgen 102
Post-approval studies (Phase 4)Study completedNCT04177940
What this trial is testing

Denosumab (DMAB) Discontinuation And Switching In Glucocorticoid-Induced Osteoporosis (GIOP): A Pilot Study

Who this might be right for
Osteoporosis
University of Alabama at Birmingham 45
Post-approval studies (Phase 4)Study completedNCT01753856
What this trial is testing

Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis
Eli Lilly and Company 69
Early research (Phase 1)UnknownNCT04213105
What this trial is testing

Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults

Who this might be right for
Healthy People
Qilu Pharmaceutical Co., Ltd. 144
Testing effectiveness (Phase 2)Ended earlyNCT01864798
What this trial is testing

Evaluate Denosumab in Young Patients With Primary Breast Cancer

Who this might be right for
Breast Neoplasms
Jules Bordet Institute 27
Large-scale testing (Phase 3)Ended earlyNCT02129699
What this trial is testing

Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy

Who this might be right for
Lung Cancer Non-small Cell Stage IV
ETOP IBCSG Partners Foundation 595
Early research (Phase 1)Study completedNCT04621318
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects

Who this might be right for
Healthy
Samsung Bioepis Co., Ltd. 168
Large-scale testing (Phase 3)Study completedNCT00321620
What this trial is testing

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer

Who this might be right for
Bone Metastases
Amgen 1,904
Testing effectiveness (Phase 2)Looking for participantsNCT03755193
What this trial is testing

Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients

Who this might be right for
Osteoporosis
Shinshu University 90
Post-approval studies (Phase 4)Active Not RecruitingNCT03623633
What this trial is testing

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis
Massachusetts General Hospital 51
Not applicableLooking for participantsNCT06728462
What this trial is testing

Amorphous Calcium Carbonate in Postmenopausal Women

Who this might be right for
CalciumOsteoporosisBone Mineral Density+2 more
Universal Integrated Corp. 205
Not applicableUnknownNCT05662358
What this trial is testing

Denosumab vs Alendronate After Vertebroplasty

Who this might be right for
Denosumab Allergy
Shenzhen People's Hospital 90
Post-approval studies (Phase 4)Study completedNCT02176382
What this trial is testing

Denosumab and Teriparatide Study (DATA-HD and DATA-EX)

Who this might be right for
Postmenopausal Osteoporosis
Massachusetts General Hospital 76
Large-scale testing (Phase 3)UnknownNCT05853354
What this trial is testing

Comparative Efficacy, Safety, PK, and Immunogenicity Study

Who this might be right for
Osteoporosis, Postmenopausal
Luye Pharma Group Ltd. 392
Post-approval studies (Phase 4)Study completedNCT03087851
What this trial is testing

Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis

Who this might be right for
Osteoporosis
Aarhus University Hospital 61
Not applicableStudy completedNCT05736640
What this trial is testing

Osseointegrated Transdermal Femoral Amputation Prostheses

Who this might be right for
Osseointegrated ImplantsBone Mineral Density
University of Aarhus 6
Large-scale testing (Phase 3)Looking for participantsNCT07062978
What this trial is testing

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

Who this might be right for
Postmenopausal Women With Osteoporosis at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd. 278
Large-scale testing (Phase 3)Study completedNCT00325468
What this trial is testing

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Low Bone Mineral Density
Amgen 200
Not applicableStudy completedNCT01967160
What this trial is testing

Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid

Who this might be right for
Osteonecrosis of the JawInfection Leading to Hospitalization
Amgen 2,560
Large-scale testing (Phase 3)Study completedNCT05345691
What this trial is testing

Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Women With Osteoporosis
Biocon Biologics UK Ltd 479
Next Page